Literature DB >> 30711941

Chloroquine Enhances Rapamycin-induced Apoptosis in MG63 Cells.

Yoichi Ishibashi1, Osamu Nakamura2, Yoshiki Yamagami1, Hideki Nishimura1, Natsuko Fukuoka1, Tetsuji Yamamoto1.   

Abstract

BACKGROUND/AIM: We previously showed that the use of autophagy inhibitors in combination with chemotherapy can enhance anticancer effects in sarcoma cell lines. In this study, we investigated the combined effect of the autophagy inhibitor chloroquine and the mTOR inhibitor rapamycin on MG63 osteosarcoma cells.
MATERIALS AND METHODS: Effects of chloroquine and/or rapamycin on cell proliferation were assessed by WST-1 assays. Effects of chloroquine and/or rapamycin on the mTOR pathway components, autophagy, and apoptosis were investigated by western blot, flow cytometry, and fluorescence microscopy using immunocytochemical staining of LC3 and Annexin V-FITC/propidium iodide.
RESULTS: Rapamycin suppressed cell growth and inhibited the mTOR pathway. Rapamycin promoted autophagy by blocking the mTOR pathway, and chloroquine enhanced apoptosis by blocking autophagy.
CONCLUSION: Chloroquine enhances the effects of rapamycin in inducing apoptosis via autophagy inhibition in MG63 cells. Thus, the combined therapy of chloroquine and rapamycin may be a potent treatment for osteosarcoma. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Rapamycin; apoptosis; autophagy; chloroquine; osteosarcoma

Mesh:

Substances:

Year:  2019        PMID: 30711941     DOI: 10.21873/anticanres.13159

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Crosstalk between autophagy and microbiota in cancer progression.

Authors:  Yu Wang; Jiang Du; Xuemei Wu; Ahmed Abdelrehem; Yu Ren; Chao Liu; Xuan Zhou; Sinan Wang
Journal:  Mol Cancer       Date:  2021-12-11       Impact factor: 27.401

2.  Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma.

Authors:  Yixuan Lin; Yiqi Yang; Kai Yuan; Shengbing Yang; Shuhong Zhang; Hanjun Li; Tingting Tang
Journal:  Bioact Mater       Date:  2022-03-29

Review 3.  Sestrin2 in cancer: a foe or a friend?

Authors:  Moein Ala
Journal:  Biomark Res       Date:  2022-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.